Why the study?
Does higher admission plasma glucose increase 30-day mortality in nondiabetic patients undergoing primary isolated CABG?
Population
878 consecutive nondiabetic patients undergoing primary isolated coronary artery bypass grafting from 1993…
Comparison
Higher admission plasma glucose vs Lower admission plasma glucose
Design
Cohort
Follow-up
30 days
Authors
Loading...
Higher admission glucose associated with 30-day CABG mortality in nondiabetic women but not men; leaves open sex-specific risk stratification pending prospective validation.
Does higher admission plasma glucose increase 30-day mortality in nondiabetic patients undergoing primary isolated CABG?
Admission plasma glucose >6.0 mmol/l is associated with increased 30-day mortality after primary isolated CABG in nondiabetic women, but not in men.
Zindrou et al. (2001) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: